Among secondary end points , levels of - glutamyl transpeptidase decreased 48 % -63 % , on average , among subjects given OCA , vs a 7 % decrease in the group given placebo ; levels of alanine aminotransferase decreased 21 % -35 % on average among subjects given OCA vs none of the patients given placebo .